Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
NEW YORK (Reuters Health) – The results of a small phase II trial suggest that stereotactic body radiotherapy (SBRT), which involves a higher dose but shorter course than…
NEW YORK (Reuters Health) – The use of aspirin as a cardioprotective agent significantly reduces recurrence among patients being treated for high-grade, non-muscle-invasive bladder cancer, the results of…
NEW YORK (Reuters Health) – The results of the largest ovarian cancer screening trial to date suggest that a transvaginal ultrasound strategy or a multimodal approach that includes…
NEW YORK (Reuters Health) – Women with migraines during pregnancy are at increased risk for stroke, MI, and other vascular disorders, according to a report in the March…
NEW YORK (Reuters Health) – Contrary to findings from a Dutch study, the results of a Swedish study suggest that long-term dietary intake of acrylamide does not raise…
David M. Cognetti, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses the evolution of treatment modalities for head and neck cancers.…
William Keane, MD, Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses treatment for common head and neck cancers using surgery and chemo/radiotherapy. References…
David M. Cognetti, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, discusses optimal care for head and neck cancer patients. Sponsored by…
NEW YORK (Reuters Health) – High blood pressure accounts for some of the disproportionately higher mortality rates among African American patients with breast cancer compared with Caucasian patients,…
NEW YORK (Reuters Health) – An analysis of data from the Health Professionals Follow-up Study confirms that men with diabetes mellitus are less prone to develop prostate cancer…
